Evidence map›Paper›PMID 23603763›Full record

SynthesisNature genetics2013

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Jimmy Z Liu, Johannes Roksund Hov, Trine Folseraas, Eva Ellinghaus, Simon M Rushbrook, Nadezhda T Doncheva, Ole A Andreassen, Rinse K Weersma, Tobias J Weismüller, Bertus Eksteen and 77 more

Open access · bronzeAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 211 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
211citing papers in PubMed, 6 pooled it
20.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

211 citing papers in PubMed, 6 syntheses or guidelines pooled it, 393 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Unmet needs in autoimmune liver diseases.Current opinion in immunology · 2025
    Review
  18. Article
  19. Article
  20. Article

151 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

87 authors at 20 institutions in 15 countries.

Jimmy Z LiuWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK.
Johannes Roksund Hov
Trine Folseraas
Eva Ellinghaus
Simon M Rushbrook
Nadezhda T Doncheva
Ole A Andreassen
Rinse K Weersma
Tobias J Weismüller
Bertus Eksteen
Pietro Invernizzi
Gideon M Hirschfield
Daniel Nils Gotthardt
Albert Pares
David Ellinghaus
Tejas Shah
Brian D Juran
Piotr Milkiewicz
Christian Rust
Christoph Schramm
Tobias Müller
Brijesh Srivastava
Georgios Dalekos
Markus M Nöthen
Stefan Herms
Juliane Winkelmann
Mitja Mitrovic
Felix Braun
Cyriel Y Ponsioen
Peter J P Croucher
Martina Sterneck
Andreas Teufel
Andrew L Mason
Janna Saarela
Virpi Leppa
Ruslan Dorfman
Domenico Alvaro
Annarosa Floreani
Suna Onengut-Gumuscu
Stephen S Rich
Wesley K Thompson
Andrew J Schork
Sigrid Næss
Ingo Thomsen
Gabriele Mayr
Inke R König
Kristian Hveem
Isabelle Cleynen
Javier Gutierrez-Achury
Isis Ricaño-Ponce
David van Heel
Einar Björnsson
Richard N Sandford
Peter R Durie
Espen Melum
Morten H Vatn
Mark S Silverberg
Richard H Duerr
Leonid Padyukov
Stephan Brand
Miquel Sans
Vito Annese
Jean-Paul Achkar
Kirsten Muri Boberg
Hanns-Ulrich Marschall
Olivier Chazouillères
Christopher L Bowlus
Cisca Wijmenga
Erik Schrumpf
Severine Vermeire
Mario Albrecht
UK-PSCSC Consortium
John D Rioux
Graeme Alexander
Annika Bergquist
Judy Cho
Stefan Schreiber
Michael P Manns
Martti Färkkilä
Anders M Dale
Roger W Chapman
Konstantinos N Lazaridis
International PSC Study Group
Andre Franke
Carl A Anderson
Tom H Karlsen
International IBD Genetics Consortium
Oslo University Hospital · NOUniversity Medical Center Groningen · NLChristian-Albrechts-Universität zu Kiel · DEKarolinska University Hospital · SEMayo Clinic · USUniversität Hamburg · DEWellcome Sanger Institute · GBUniversity of Bonn · DEUniversity of California San Diego · USUniversity of Cambridge · GBUniversity of Helsinki · FIUniversity of Oslo · NOAmsterdam UMC Location University of Amsterdam · NLHelsinki University Hospital · FIHumanitas University · ITNational Health Service · GBNorwegian University of Science and Technology · NOReykjavík University · ISUniversitätsmedizin Greifswald · DEUniversité Paris Cité · FR

Funding

University of Pittsburgh Clinical and Translational Science InstituteUL1TR000005 · NCATS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI REIS, STEVEN E · 2012 to 2015
$50.8M
NIDDK IBD Genetics Consortium Genetic Research CenterU01DK062420 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2002 to 2021
$7.8M
Impact of Genetic Variability on Cellular Pathways and Host-Microbiome InteractioU01DK062423 · NIDDK · SINAI HEALTH SYSTEM · PI MARK S. SILVERBERG · 2002 to 2026
$7.5M
Replication of Association Signals Identified in Ulcerative Colitis GWASR01CA141743 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DUERR, RICHARD H · 2009 to 2010
$600k
Chief Scientist Office CZB/4/540Chief Scientist Office ETM/137Chief Scientist Office ETM/75Medical Research Council G0600329Medical Research Council G0601816Medical Research Council G0800675Medical Research Council G0800759NCATS NIH HHS UL1 TR000005NCI NIH HHS R01 CA141743NIDDK NIH HHS U01 DK062420NIDDK NIH HHS U01 DK062423Wellcome Trust 091745Wellcome Trust 098051
6 · The paper itself

Abstract

Primary sclerosing cholangitis (PSC) is a severe liver disease of unknown etiology leading to fibrotic destruction of the bile ducts and ultimately to the need for liver transplantation. We compared 3,789 PSC cases of European ancestry to 25,079 population controls across 130,422 SNPs genotyped using the Immunochip. We identified 12 genome-wide significant associations outside the human leukocyte antigen (HLA) complex, 9 of which were new, increasing the number of known PSC risk loci to 16. Despite comorbidity with inflammatory bowel disease (IBD) in 72% of the cases, 6 of the 12 loci showed significantly stronger association with PSC than with IBD, suggesting overlapping yet distinct genetic architectures for these two diseases. We incorporated association statistics from 7 diseases clinically occurring with PSC in the analysis and found suggestive evidence for 33 additional pleiotropic PSC risk loci. Together with network analyses, these findings add to the genetic risk map of PSC and expand on the relationship between PSC and other immune-mediated diseases.

Indexed as

Case-Control StudiesCholangitis, SclerosingGene FrequencyGenetic LociGenetic PleiotropyGenome-Wide Association StudyGenotyping TechniquesHumansLinkage DisequilibriumOligonucleotide Array Sequence AnalysisPolymorphism, Single NucleotideRisk Factors

Identifiers

PMID23603763
PMCPMC3667736
OpenAlexW2130462669

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.